tiprankstipranks
Trending News
More News >
Zomedica (ZOMDF)
OTHER OTC:ZOMDF
US Market
Advertisement

Zomedica (ZOMDF) Price & Analysis

Compare
4,798 Followers

ZOMDF Stock Chart & Stats

$0.08
--
Market closed
$0.08
--

Bulls Say, Bears Say

Bulls Say
Financial PerformanceFinancial results show continued growth in an expanding market, meeting growth expectations both sequentially and in year-over-year comparisons.
Product InnovationZomedica has introduced several new assays for use with its TRUFORMA diagnostics platform, allowing veterinary practices to run tests without sending samples to an outside lab.
Sales GrowthThe TRUFORMA assays have been one of the sources of sales growth over the past year.
Bears Say
Price WeaknessAlthough Zomedica has made fundamental progress, the price weakness led to delisting and further price weakness.
Stock Price And DelistingThe closing price of Zomedica stock fell below $0.10 per share, forcing the delisting of ZOM shares.

Zomedica News

ZOMDF FAQ

What was Zomedica’s price range in the past 12 months?
Zomedica lowest stock price was $0.01 and its highest was $0.16 in the past 12 months.
    What is Zomedica’s market cap?
    Zomedica’s market cap is $75.36M.
      When is Zomedica’s upcoming earnings report date?
      Zomedica’s upcoming earnings report date is Mar 04, 2026 which is in 116 days.
        How were Zomedica’s earnings last quarter?
        Zomedica released its earnings results on Nov 04, 2025. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
          Is Zomedica overvalued?
          According to Wall Street analysts Zomedica’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Zomedica pay dividends?
            Zomedica does not currently pay dividends.
            What is Zomedica’s EPS estimate?
            Zomedica’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Zomedica have?
            Zomedica has 979,949,650 shares outstanding.
              What happened to Zomedica’s price movement after its last earnings report?
              Zomedica reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.579%.
                Which hedge fund is a major shareholder of Zomedica?
                Currently, no hedge funds are holding shares in ZOMDF

                Company Description

                Zomedica

                Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. The company was founded by Gerald L. Solensky, Jr. on January 7, 2013 and is headquartered in Ann Arbor, MI.

                Zomedica (ZOMDF) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                aTyr Pharma
                vTv Therapeutics
                Relmada Therapeutics
                PMV Pharmaceuticals
                Pulmonx

                Ownership Overview

                2.57%0.03%0.07%97.33%
                0.07% Other Institutional Investors
                97.33% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis